TEXT-EXTRACT 2 filename2.txt United States securities and exchange commission logo October 24, 2022 Lisa Ricciardi President and Chief Executive Officer Cognition Therapeutics, Inc. 2500 Westchester Ave. Purchase, NY 10577 Re: Cognition Therapeutics, Inc. Draft Registration Statement on Form S-1 Submitted October 20, 2022 CIK No. 0001455365 Dear Lisa Ricciardi: This is to advise you that we do not intend to review your registration statement. We request that you publicly file your registration statement no later than 48 hours prior to the requested effective date and time. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Joshua Gorsky at 202-551-7836 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Rachael M. Bushey